Hans Garmo

Comparison of software vs. cognitive-based fusion-targeted biopsies for prostate cancer diagnosis

Westerberg, Marcus; Gedeborg, Rolf; Garmo, Hans; Jäderling, Fredrik et al.

Part of BJUI Compass, 2026

• DOI for Comparison of software vs. cognitive-based fusion-targeted biopsies for prostate cancer diagnosis
• Download full text (pdf) of Comparison of software vs. cognitive-based fusion-targeted biopsies for prostate cancer diagnosis

Long-term Outcomes in Men with Stable PSA During 5-a Reductase Inhibitor Thera py After Negative Prostate Biopsy: Population-based Study

Ventimiglia, Eugenio; Westerberg, Marcus; Wilberg Orrason, Andri; Ahlberg, Mats et al.

Part of European Urology Open Science, p. 72-76, 2026

• DOI for Long-term Outcomes in Men with Stable PSA During 5-a Reductase Inhibitor Thera py After Negative Prostate Biopsy: Population-based Study
• Download full text (pdf) of Long-term Outcomes in Men with Stable PSA During 5-a Reductase Inhibitor Thera py After Negative Prostate Biopsy: Population-based Study

Estimation and Prognostic Role of Prostate-specific Antigen (PSA) Doubling Time After Radical Prostatectomy

Scilipoti, Pietro; Callenmark, Max; Garmo, Hans; Stattin, Pär et al.

Part of European Urology Open Science, p. 1-9, 2026

• DOI for Estimation and Prognostic Role of Prostate-specific Antigen (PSA) Doubling Time After Radical Prostatectomy
• Download full text (pdf) of Estimation and Prognostic Role of Prostate-specific Antigen (PSA) Doubling Time After Radical Prostatectomy

Extent of prostate cancer cases not registered in The National Cancer Register of Sweden and consequences for estimates of prostate cancer incidence and mortality

Ventimiglia, Eugenio; Garmo, Hans; Gedeborg, Rolf; Ahlberg, Mats et al.

Part of Acta Oncologica, p. 297-300, 2026

• DOI for Extent of prostate cancer cases not registered in The National Cancer Register of Sweden and consequences for estimates of prostate cancer incidence and mortality
• Download full text (pdf) of Extent of prostate cancer cases not registered in The National Cancer Register of Sweden and consequences for estimates of prostate cancer incidence and mortality

Temporal trends in diagnostic work-up, treatment, and mortality in locally advanced prostate cancer in 2016-2024: nationwide, population-based study in Sweden

Galdieri, Armando; Garmo, Hans; Gedeborg, Rolf; Ahlberg, Mats et al.

Part of Acta Oncologica, p. 282-288, 2026

• DOI for Temporal trends in diagnostic work-up, treatment, and mortality in locally advanced prostate cancer in 2016-2024: nationwide, population-based study in Sweden
• Download full text (pdf) of Temporal trends in diagnostic work-up, treatment, and mortality in locally advanced prostate cancer in 2016-2024: nationwide, population-based study in Sweden

Comparison of software vs. cognitive-based fusion-targeted biopsies for prostate cancer diagnosis

Westerberg, Marcus; Gedeborg, Rolf; Garmo, Hans; Jäderling, Fredrik et al.

Part of BJUI Compass, 2026

• DOI for Comparison of software vs. cognitive-based fusion-targeted biopsies for prostate cancer diagnosis
• Download full text (pdf) of Comparison of software vs. cognitive-based fusion-targeted biopsies for prostate cancer diagnosis

Long-term Outcomes in Men with Stable PSA During 5-a Reductase Inhibitor Thera py After Negative Prostate Biopsy: Population-based Study

Ventimiglia, Eugenio; Westerberg, Marcus; Wilberg Orrason, Andri; Ahlberg, Mats et al.

Part of European Urology Open Science, p. 72-76, 2026

• DOI for Long-term Outcomes in Men with Stable PSA During 5-a Reductase Inhibitor Thera py After Negative Prostate Biopsy: Population-based Study
• Download full text (pdf) of Long-term Outcomes in Men with Stable PSA During 5-a Reductase Inhibitor Thera py After Negative Prostate Biopsy: Population-based Study

Estimation and Prognostic Role of Prostate-specific Antigen (PSA) Doubling Time After Radical Prostatectomy

Scilipoti, Pietro; Callenmark, Max; Garmo, Hans; Stattin, Pär et al.

Part of European Urology Open Science, p. 1-9, 2026

• DOI for Estimation and Prognostic Role of Prostate-specific Antigen (PSA) Doubling Time After Radical Prostatectomy
• Download full text (pdf) of Estimation and Prognostic Role of Prostate-specific Antigen (PSA) Doubling Time After Radical Prostatectomy

Extent of prostate cancer cases not registered in The National Cancer Register of Sweden and consequences for estimates of prostate cancer incidence and mortality

Ventimiglia, Eugenio; Garmo, Hans; Gedeborg, Rolf; Ahlberg, Mats et al.

Part of Acta Oncologica, p. 297-300, 2026

• DOI for Extent of prostate cancer cases not registered in The National Cancer Register of Sweden and consequences for estimates of prostate cancer incidence and mortality
• Download full text (pdf) of Extent of prostate cancer cases not registered in The National Cancer Register of Sweden and consequences for estimates of prostate cancer incidence and mortality

Temporal trends in diagnostic work-up, treatment, and mortality in locally advanced prostate cancer in 2016-2024: nationwide, population-based study in Sweden

Galdieri, Armando; Garmo, Hans; Gedeborg, Rolf; Ahlberg, Mats et al.

Part of Acta Oncologica, p. 282-288, 2026

• DOI for Temporal trends in diagnostic work-up, treatment, and mortality in locally advanced prostate cancer in 2016-2024: nationwide, population-based study in Sweden
• Download full text (pdf) of Temporal trends in diagnostic work-up, treatment, and mortality in locally advanced prostate cancer in 2016-2024: nationwide, population-based study in Sweden

Comparing multifocal with unifocal breast cancer and the relationship with survival: national cohort study

Söderberg, Emma; Wärnberg, Fredrik; Wennstig, Anna-Karin; Nilsson, Greger et al.

Part of BJS, 2026

• DOI for Comparing multifocal with unifocal breast cancer and the relationship with survival: national cohort study
• Download full text (pdf) of Comparing multifocal with unifocal breast cancer and the relationship with survival: national cohort study

Consequences of different definitions of disease progression in observational studies of men with advanced prostate cancer

Ventimiglia, Eugenio; Westerberg, Marcus; Zaurito, Paolo; Miranda, Tiago Bonde et al.

Part of Scandinavian journal of urology, p. 22-28, 2026

• DOI for Consequences of different definitions of disease progression in observational studies of men with advanced prostate cancer
• Download full text (pdf) of Consequences of different definitions of disease progression in observational studies of men with advanced prostate cancer

Uptake of doublet and triplet therapy for men with de novo metastatic castration-sensitive prostate cancer. Population-based study

Zaurito, Paolo; Gedeborg, Rolf; Garmo, Hans; Ventimiglia, Eugenio et al.

Part of Scandinavian journal of urology, p. 51-57, 2026

• DOI for Uptake of doublet and triplet therapy for men with de novo metastatic castration-sensitive prostate cancer. Population-based study
• Download full text (pdf) of Uptake of doublet and triplet therapy for men with de novo metastatic castration-sensitive prostate cancer. Population-based study

Nationwide population-based longitudinal data on magnetic resonance imaging of the prostate and subsequent prostate biopsy results

Ventimiglia, Eugenio; Gedeborg, Rolf; Westerberg, Marcus; Zaurito, Paolo et al.

Part of Scandinavian journal of urology, p. 64-71, 2026

• DOI for Nationwide population-based longitudinal data on magnetic resonance imaging of the prostate and subsequent prostate biopsy results
• Download full text (pdf) of Nationwide population-based longitudinal data on magnetic resonance imaging of the prostate and subsequent prostate biopsy results

Prostate cancer characteristics in fathers and risk of early onset high-risk prostate cancer in sons

Lin, E.; Garmo, Hans; Beckmann, Kerri; Bratt, Ola et al.

Part of International Journal of Cancer, p. 977-983, 2026

• DOI for Prostate cancer characteristics in fathers and risk of early onset high-risk prostate cancer in sons
• Download full text (pdf) of Prostate cancer characteristics in fathers and risk of early onset high-risk prostate cancer in sons

Urinary tract events after radical radiotherapy (RT) for prostate cancer according to pre-RT International Prostate Symptom Score

Zaurito, Paolo; Westerberg, Marcus; Garmo, Hans; Gedeborg, Rolf et al.

Part of BJU International, p. 103-111, 2026

• DOI for Urinary tract events after radical radiotherapy (RT) for prostate cancer according to pre-RT International Prostate Symptom Score
• Download full text (pdf) of Urinary tract events after radical radiotherapy (RT) for prostate cancer according to pre-RT International Prostate Symptom Score

Incidence and prognostic implications of PSA relapse after radical radiotherapy for prostate cancer: a population-based study

Zaurito, Paolo; Garmo, Hans; Gedeborg, Rolf; Ahlberg, Mats et al.

Part of BJU International, p. 629-638, 2026

• DOI for Incidence and prognostic implications of PSA relapse after radical radiotherapy for prostate cancer: a population-based study
• Download full text (pdf) of Incidence and prognostic implications of PSA relapse after radical radiotherapy for prostate cancer: a population-based study

Routinely collected health data on 10-year genitourinary and gastrointestinal morbidity after ultra-hypofractionated versus conventionally fractionated radiotherapy for localised prostate cancer in the randomised, non-inferiority, phase 3 trial HYPO-RT-PC

Persson, Astrid E.; Kjellén, Elisabeth; Garmo, Hans; Adrian, Gabriel et al.

Part of Radiotherapy and Oncology, 2026

• DOI for Routinely collected health data on 10-year genitourinary and gastrointestinal morbidity after ultra-hypofractionated versus conventionally fractionated radiotherapy for localised prostate cancer in the randomised, non-inferiority, phase 3 trial HYPO-RT-PC
• Download full text (pdf) of Routinely collected health data on 10-year genitourinary and gastrointestinal morbidity after ultra-hypofractionated versus conventionally fractionated radiotherapy for localised prostate cancer in the randomised, non-inferiority, phase 3 trial HYPO-RT-PC

Suicide risk among urinary bladder cancer patients compared with the standard population: a nationwide study in Sweden

Hawez, Lewar; Bergengren, Oskar; Ahlberg, Mats; Garmo, Hans et al.

Part of Scandinavian journal of urology, p. 204-208, 2025

• DOI for Suicide risk among urinary bladder cancer patients compared with the standard population: a nationwide study in Sweden
• Download full text (pdf) of Suicide risk among urinary bladder cancer patients compared with the standard population: a nationwide study in Sweden

Radium-223 use and survival by line of treatment in metastatic castration-resistant prostate cancer: a nationwide population-based register study

Alverbratt, Charlotte; Sandin, Fredrik; Kolmbäck, Viktor; Garmo, Hans et al.

Part of Acta Oncologica, p. 1391-1403, 2025

• DOI for Radium-223 use and survival by line of treatment in metastatic castration-resistant prostate cancer: a nationwide population-based register study
• Download full text (pdf) of Radium-223 use and survival by line of treatment in metastatic castration-resistant prostate cancer: a nationwide population-based register study

A Modular Framework for Treatment Effect Estimation in Latent Subgroups

Lindhagen, Lars; Garmo, Hans; Östlund, Ollie

Part of Journal of Statistical Theory and Applications, p. 1064-1090, 2025

• DOI for A Modular Framework for Treatment Effect Estimation in Latent Subgroups
• Download full text (pdf) of A Modular Framework for Treatment Effect Estimation in Latent Subgroups

Prostate cancer incidence in Sweden before, during and after the COVID-19 pandemic. Population-based study

Zaurito, Paolo; Garmo, Hans; Gedeborg, Rolf; Ahlberg, Mats et al.

Part of Scandinavian journal of urology, p. 93-96, 2025

• DOI for Prostate cancer incidence in Sweden before, during and after the COVID-19 pandemic. Population-based study
• Download full text (pdf) of Prostate cancer incidence in Sweden before, during and after the COVID-19 pandemic. Population-based study

A comparison of comorbidity indices and estimates of life expectancy for men with prostate cancer

Ventimiglia, Eugenio; Gedeborg, Rolf; Orrason, Andri Wilberg; Zaurito, Paolo et al.

Part of Scandinavian journal of urology, p. 105-107, 2025

• DOI for A comparison of comorbidity indices and estimates of life expectancy for men with prostate cancer
• Download full text (pdf) of A comparison of comorbidity indices and estimates of life expectancy for men with prostate cancer

Incidence and prognostic implications of prostate-specific antigen persistence and relapse after radical prostatectomy: population-based study

Scilipoti, Pietro; Garmo, Hans; Gedeborg, Rolf; Robinson, David et al.

Part of Journal of the National Cancer Institute, p. 1142-1150, 2025

• DOI for Incidence and prognostic implications of prostate-specific antigen persistence and relapse after radical prostatectomy: population-based study
• Download full text (pdf) of Incidence and prognostic implications of prostate-specific antigen persistence and relapse after radical prostatectomy: population-based study

Investigation into the clinical features, treatment patterns, and survival of older men with prostate cancer in Sweden and Belgium

George, G.; Axelson, A. B.; Decaestecker, K.; Garmo, H. et al.

Part of ESMO Real World Data and Digital Oncology, 2025

• DOI for Investigation into the clinical features, treatment patterns, and survival of older men with prostate cancer in Sweden and Belgium
• Download full text (pdf) of Investigation into the clinical features, treatment patterns, and survival of older men with prostate cancer in Sweden and Belgium

Guidelines and variations in patterns of GnRH analogue use in castration-resistant prostate cancer across six countries

George, G.; Enting, D.; Garmo, Hans; Stattin, Pär et al.

Part of ESMO Real World Data and Digital Oncology, 2025

• DOI for Guidelines and variations in patterns of GnRH analogue use in castration-resistant prostate cancer across six countries
• Download full text (pdf) of Guidelines and variations in patterns of GnRH analogue use in castration-resistant prostate cancer across six countries

Family History of Early Onset or Lethal Prostate Cancer and the Risk of Prostate Cancer Death in Sweden

Lin, E; Garmo, Hans; Beckmann, Kerri; Bratt, Ola et al.

Part of Cancer Epidemiology, Biomarkers and Prevention, p. 1585-1592, 2025

• DOI for Family History of Early Onset or Lethal Prostate Cancer and the Risk of Prostate Cancer Death in Sweden
• Download full text (pdf) of Family History of Early Onset or Lethal Prostate Cancer and the Risk of Prostate Cancer Death in Sweden

Optimised comorbidity indices can reflect patient performance status in register based studies of prostate cancer

Westerberg, Marcus; Garmo, Hans; Bonnedahl, Jesper; Eriksson, Marie Hjälm et al.

Part of Scientific Reports, 2025

• DOI for Optimised comorbidity indices can reflect patient performance status in register based studies of prostate cancer
• Download full text (pdf) of Optimised comorbidity indices can reflect patient performance status in register based studies of prostate cancer

Adaption of the Memorial Sloan Kettering Cancer Center Nomograms for the Prediction of Pros tate Cancer-specific Death in Sweden: A Population-based Cohort Study

Zelic, Renata; Westerberg, Marcus; Stattin, Pär; Garmo, Hans et al.

Part of European Urology Open Science, p. 41-50, 2025

• DOI for Adaption of the Memorial Sloan Kettering Cancer Center Nomograms for the Prediction of Pros tate Cancer-specific Death in Sweden: A Population-based Cohort Study
• Download full text (pdf) of Adaption of the Memorial Sloan Kettering Cancer Center Nomograms for the Prediction of Pros tate Cancer-specific Death in Sweden: A Population-based Cohort Study

Potential gains from radical treatment of men with prostate cancer according to life expectancy

Irenaeus, Sandra; Garmo, Hans; Gedeborg, Rolf; Ahlberg, Mats et al.

Part of BJUI Compass, 2025

• DOI for Potential gains from radical treatment of men with prostate cancer according to life expectancy
• Download full text (pdf) of Potential gains from radical treatment of men with prostate cancer according to life expectancy

Sociodemographic disparities in incidence rates of advanced and low-risk prostate cancer as a proxy for diagnostic activity

Strömberg, Ulf; Bonander, Carl; Garmo, Hans; Lambe, Mats et al.

Part of Acta Oncologica, p. 677-684, 2025

• DOI for Sociodemographic disparities in incidence rates of advanced and low-risk prostate cancer as a proxy for diagnostic activity
• Download full text (pdf) of Sociodemographic disparities in incidence rates of advanced and low-risk prostate cancer as a proxy for diagnostic activity

Gleason scores provide more accurate prognostic information than grade groups

Egevad, Lars; Micoli, Chiara; Delahunt, Brett; Samaratunga, Hemamali et al.

Part of Pathology, p. 293-296, 2025

• DOI for Gleason scores provide more accurate prognostic information than grade groups
• Download full text (pdf) of Gleason scores provide more accurate prognostic information than grade groups

Long-Term Outcomes After Guideline-Recommended Treatment of Men With Prostate Cancer

Scilipoti, Pietro; Bratt, Ola; Garmo, Hans; Wilberg Orrason, Andri et al.

Part of The Journal of the National Comprehensive Cancer Network, 2025

• DOI for Long-Term Outcomes After Guideline-Recommended Treatment of Men With Prostate Cancer

Cohort Profile Update: The National Prostate Cancer Register of Sweden and PCBase

Westerberg, Marcus; Holm, Lennart; Garmo, Hans; Stattin, Pär et al.

Part of International Journal of Epidemiology, 2025

• DOI for Cohort Profile Update: The National Prostate Cancer Register of Sweden and PCBase
• Download full text (pdf) of Cohort Profile Update: The National Prostate Cancer Register of Sweden and PCBase

Time Dependence of Outcomes in the SPCG-4 Randomized Trial Comparing Radical Prostatectomy and Watchful Waiting in Early Prostate Cancer.

Holmberg, Lars; Garmo, H.; Andersson, Sven-Olov; Andrén, Ove et al.

Part of European Urology, p. 554-558, 2025

• DOI for Time Dependence of Outcomes in the SPCG-4 Randomized Trial Comparing Radical Prostatectomy and Watchful Waiting in Early Prostate Cancer.
• Download full text (pdf) of Time Dependence of Outcomes in the SPCG-4 Randomized Trial Comparing Radical Prostatectomy and Watchful Waiting in Early Prostate Cancer.

Discriminative Ability of the Charlson Comorbidity Index for Long-Term Mortality in a General Population: Nationwide, Population-Based Study of 10 Million Adults in Sweden

Westerberg, Marcus; Garmo, H.; Ludvigsson, Jonas; Stattin, Pär et al.

Part of Clinical Epidemiology, p. 983-993, 2025

• DOI for Discriminative Ability of the Charlson Comorbidity Index for Long-Term Mortality in a General Population: Nationwide, Population-Based Study of 10 Million Adults in Sweden
• Download full text (pdf) of Discriminative Ability of the Charlson Comorbidity Index for Long-Term Mortality in a General Population: Nationwide, Population-Based Study of 10 Million Adults in Sweden

Triggers for transition from active surveillance to radical treatment of prostate cancer 2008-2020 – a case control study

Ahlberg, Mats Steinholtz; Garmo, Hans; Stattin, Pär; Gedeborg, Rolf et al.

Part of Scandinavian journal of urology, p. 63-69, 2024

• DOI for Triggers for transition from active surveillance to radical treatment of prostate cancer 2008-2020 – a case control study
• Download full text (pdf) of Triggers for transition from active surveillance to radical treatment of prostate cancer 2008-2020 – a case control study

Prognosis of Gleason Score 9-10 Prostatic Adenocarcinoma in Needle Biopsies: A Nationwide Population-based Study

Egevad, Lars; Micoli, Chiara; Samaratunga, Hemamali; Delahunt, Brett et al.

Part of European Urology Oncology, p. 213-221, 2024

• DOI for Prognosis of Gleason Score 9-10 Prostatic Adenocarcinoma in Needle Biopsies: A Nationwide Population-based Study
• Download full text (pdf) of Prognosis of Gleason Score 9-10 Prostatic Adenocarcinoma in Needle Biopsies: A Nationwide Population-based Study

Association of clinicopathologic variables and patient preference with the choice of surgical treatment for early-stage breast cancer: A registry-based study

Söderberg, Emma; Wärnberg, Fredrik; Wennstig, Anna-Karin; Nilsson, Greger et al.

Part of The Breast, 2024

• DOI for Association of clinicopathologic variables and patient preference with the choice of surgical treatment for early-stage breast cancer: A registry-based study
• Download full text (pdf) of Association of clinicopathologic variables and patient preference with the choice of surgical treatment for early-stage breast cancer: A registry-based study

Natural History of Nonmetastatic Prostate Cancer Managed With Watchful Waiting

Ventimiglia, Eugenio; Gedeborg, Rolf; Styrke, Johan; Robinson, David et al.

Part of JAMA Network Open, 2024

• DOI for Natural History of Nonmetastatic Prostate Cancer Managed With Watchful Waiting
• Download full text (pdf) of Natural History of Nonmetastatic Prostate Cancer Managed With Watchful Waiting

Risk of prostate cancer death in men diagnosed with prostate cancer at cystoprostatectomy. A nationwide populationbased study

Scilipoti, Pietro; Liedberg, Fredrik; Garmo, Hans; Wilberg Orrason, Andri et al.

Part of Scandinavian journal of urology, p. 98-103, 2024

• DOI for Risk of prostate cancer death in men diagnosed with prostate cancer at cystoprostatectomy. A nationwide populationbased study
• Download full text (pdf) of Risk of prostate cancer death in men diagnosed with prostate cancer at cystoprostatectomy. A nationwide populationbased study

Population-based study of disease trajectory after radical treatment for high-risk prostate cancer

Stattin, Pär; Fleming, Sarah; Lin, Xiwu; Lefresne, Florence et al.

Part of BJU International, p. 96-102, 2024

• DOI for Population-based study of disease trajectory after radical treatment for high-risk prostate cancer
• Download full text (pdf) of Population-based study of disease trajectory after radical treatment for high-risk prostate cancer

Cumulative incidence of and risk factors for BCG infection after adjuvant BCG instillations

Holmberg, Lars; Skogmar, Sten; Garmo, Hans; Hagberg, Oskar et al.

Part of BJU International, p. 229-238, 2024

• DOI for Cumulative incidence of and risk factors for BCG infection after adjuvant BCG instillations
• Download full text (pdf) of Cumulative incidence of and risk factors for BCG infection after adjuvant BCG instillations

Development and validation of a multi-dimensional diagnosis-based comorbidity index that improves prediction of death in men with prostate cancer: Nationwide, population-based register study

Westerberg, Marcus; Irenaeus, Sandra; Garmo, Hans; Stattin, Pär et al.

Part of PLOS ONE, 2024

• DOI for Development and validation of a multi-dimensional diagnosis-based comorbidity index that improves prediction of death in men with prostate cancer: Nationwide, population-based register study
• Download full text (pdf) of Development and validation of a multi-dimensional diagnosis-based comorbidity index that improves prediction of death in men with prostate cancer: Nationwide, population-based register study

Target trial emulation using new comorbidity indices provided risk estimates comparable to a randomized trial

Westerberg, Marcus; Garmo, Hans; Robinson, David; Stattin, Pär et al.

Part of Journal of Clinical Epidemiology, 2024

• DOI for Target trial emulation using new comorbidity indices provided risk estimates comparable to a randomized trial
• Download full text (pdf) of Target trial emulation using new comorbidity indices provided risk estimates comparable to a randomized trial

Immune cell infiltrate in ductal carcinoma in situ and the risk of dying from breast cancer: case-control study

Rask, Gunilla; Wadsten, Charlotta; Acs, Balazs; Hartman, Johan et al.

Part of British Journal of Surgery, 2024

• DOI for Immune cell infiltrate in ductal carcinoma in situ and the risk of dying from breast cancer: case-control study
• Download full text (pdf) of Immune cell infiltrate in ductal carcinoma in situ and the risk of dying from breast cancer: case-control study

Radical Prostatectomy or Watchful Waiting in Early Prostate Cancer

Holmberg, Lars; Garmo, Hans; Andersson, Swen-Olof; Andrén, Ove et al.

Part of New England Journal of Medicine, p. 1362-1364, 2024

• DOI for Radical Prostatectomy or Watchful Waiting in Early Prostate Cancer

Patient-reported Side Effects 1 Year After Radical Prostatectomy or Radiotherapy for Prostate Cancer: A Register-based Nationwide Study

Corsini, Christian; Bergengren, Oskar; Carlsson, Stefan; Garmo, Hans et al.

Part of European Urology Oncology, p. 605-613, 2024

• DOI for Patient-reported Side Effects 1 Year After Radical Prostatectomy or Radiotherapy for Prostate Cancer: A Register-based Nationwide Study

Prognosis of Gleason score 8 prostatic adenocarcinoma in needle biopsies: a nationwide population-based study

Egevad, Lars; Micoli, Chiara; Delahunt, Brett; Samaratunga, Hemamali et al.

Part of Virchows Archiv, p. 995-1003, 2024

• DOI for Prognosis of Gleason score 8 prostatic adenocarcinoma in needle biopsies: a nationwide population-based study
• Download full text (pdf) of Prognosis of Gleason score 8 prostatic adenocarcinoma in needle biopsies: a nationwide population-based study

Evidence of cancer progression as the cause of death in men with prostate cancer in Sweden

Wilberg Orrason, Andri; Styrke, Johan; Garmo, Hans; Stattin, Pär

Part of BJU International, p. 486-493, 2023

• DOI for Evidence of cancer progression as the cause of death in men with prostate cancer in Sweden
• Download full text (pdf) of Evidence of cancer progression as the cause of death in men with prostate cancer in Sweden

Angiosarcoma in the breast: a population-based cohort from Sweden

Olander, Susanne; Wennstig, Anna-Karin; Garmo, Hans; Holmberg, Lars et al.

Part of British Journal of Surgery, p. 1850-1856, 2023

• DOI for Angiosarcoma in the breast: a population-based cohort from Sweden

Risk of prostate cancer death after radical radiotherapy with neoadjuvant and adjuvant therapy with bicalutamide or gonadotropin-releasing hormone agonists

Bonde, Tiago M.; Garmo, Hans; Stattin, Pär; Nilsson, Per et al.

Part of Acta Oncologica, p. 1815-1821, 2023

• DOI for Risk of prostate cancer death after radical radiotherapy with neoadjuvant and adjuvant therapy with bicalutamide or gonadotropin-releasing hormone agonists
• Download full text (pdf) of Risk of prostate cancer death after radical radiotherapy with neoadjuvant and adjuvant therapy with bicalutamide or gonadotropin-releasing hormone agonists

Frequency of Biopsy and Tumor Grade Before vs After Introduction of Prostate Magnetic Resonance Imaging.

Robinson, David; Abdulkareem, Rafid; Nasrollah, Delshad; Ljung, Anders et al.

Part of JAMA Network Open, 2023

• DOI for Frequency of Biopsy and Tumor Grade Before vs After Introduction of Prostate Magnetic Resonance Imaging.

Association between atherogenic lipids and GnRH agonists for prostate cancer in men with T2DM: a nationwide, population-based cohort study in Sweden

Lin, E.; Garmo, Hans; Hagström, Emil; Van Hemelrijck, Mieke et al.

Part of British Journal of Cancer, p. 814-824, 2023

• DOI for Association between atherogenic lipids and GnRH agonists for prostate cancer in men with T2DM: a nationwide, population-based cohort study in Sweden
• Download full text (pdf) of Association between atherogenic lipids and GnRH agonists for prostate cancer in men with T2DM: a nationwide, population-based cohort study in Sweden

Variations in the Uptake of Active Surveillance for Prostate Cancer and Its Impact on Outcomes

Ahlberg, Mats Steinholtz; Garmo, Hans; Holmberg, Lars; Bill-Axelson, Anna

Part of European Urology Open Science, p. 166-173, 2023

• DOI for Variations in the Uptake of Active Surveillance for Prostate Cancer and Its Impact on Outcomes
• Download full text (pdf) of Variations in the Uptake of Active Surveillance for Prostate Cancer and Its Impact on Outcomes

Uptake of doublet therapy for de novo metastatic castration sensitive prostate cancer: a population-based drug utilisation study in Sweden

Gedeborg, Rolf; Sandin, Fredrik; Thellenberg-Karlsson, Camilla; Styrke, Johan et al.

Part of Scandinavian journal of urology, p. 93-100, 2023

• DOI for Uptake of doublet therapy for de novo metastatic castration sensitive prostate cancer: a population-based drug utilisation study in Sweden
• Download full text (pdf) of Uptake of doublet therapy for de novo metastatic castration sensitive prostate cancer: a population-based drug utilisation study in Sweden

Survival Trend in Individuals With De Novo Metastatic Prostate Cancer After the Introduction of Doublet Therapy

Corsini, Christian; Garmo, Hans; Wilberg Orrason, Andri; Gedeborg, Rolf et al.

Part of JAMA Network Open, 2023

• DOI for Survival Trend in Individuals With De Novo Metastatic Prostate Cancer After the Introduction of Doublet Therapy
• Download full text (pdf) of Survival Trend in Individuals With De Novo Metastatic Prostate Cancer After the Introduction of Doublet Therapy

Population-based estimates of age and comorbidity specific life expectancy: a first application in Swedish males

Van Hemelrijck, Mieke; Ventimiglia, Eugenio; Robinson, David; Gedeborg, Rolf et al.

Part of BMC Medical Informatics and Decision Making, 2022

• DOI for Population-based estimates of age and comorbidity specific life expectancy: a first application in Swedish males
• Download full text (pdf) of Population-based estimates of age and comorbidity specific life expectancy: a first application in Swedish males

Population-based study of long-term anticoagulation for treatment and secondary prophylaxis of venous thromboembolism in men with prostate cancer in Sweden

Balabanova, Yanina; Farahmand, Bahman; Stattin, Pär; Garmo, Hans et al.

Part of BMC Urology, 2022

• DOI for Population-based study of long-term anticoagulation for treatment and secondary prophylaxis of venous thromboembolism in men with prostate cancer in Sweden
• Download full text (pdf) of Population-based study of long-term anticoagulation for treatment and secondary prophylaxis of venous thromboembolism in men with prostate cancer in Sweden

Risk of venous thromboembolism in men with prostate cancer compared with men in the general population: a nationwide population-based cohort study in Sweden

Balabanova, Yanina; Farahmand, Bahman; Garmo, Hans; Stattin, Pär et al.

Part of BMJ Open, 2022

• DOI for Risk of venous thromboembolism in men with prostate cancer compared with men in the general population: a nationwide population-based cohort study in Sweden
• Download full text (pdf) of Risk of venous thromboembolism in men with prostate cancer compared with men in the general population: a nationwide population-based cohort study in Sweden

Association of Gonadotropin-Releasing Hormone Agonists for Prostate Cancer With Cardiovascular Disease Risk and Hypertension in Men With Diabetes

Lin, E.; Garmo, Hans; Van Hemelrijck, Mieke; Zethelius, Björn et al.

Part of JAMA Network Open, 2022

• DOI for Association of Gonadotropin-Releasing Hormone Agonists for Prostate Cancer With Cardiovascular Disease Risk and Hypertension in Men With Diabetes
• Download full text (pdf) of Association of Gonadotropin-Releasing Hormone Agonists for Prostate Cancer With Cardiovascular Disease Risk and Hypertension in Men With Diabetes

Susceptibility to SARS-Cov-2 infection and risk for severe COVID-19 in patients with prostate cancer on androgen deprivation therapy

Gedeborg, Rolf; Loeb, Stacy; Styrke, Johan; Kiiski-Berggren, Ritva et al.

Part of International Journal of Cancer, p. 1925-1934, 2022

• DOI for Susceptibility to SARS-Cov-2 infection and risk for severe COVID-19 in patients with prostate cancer on androgen deprivation therapy
• Download full text (pdf) of Susceptibility to SARS-Cov-2 infection and risk for severe COVID-19 in patients with prostate cancer on androgen deprivation therapy

Time on treatment with abiraterone in men with de novo metastatic castration sensitive prostate cancer: a drug utilization study

Gedeborg, Rolf; Garmo, Hans; Thellenberg-Karlsson, Camilla; Fallara, Giuseppe et al.

Part of Acta Oncologica, p. 328-332, 2022

• DOI for Time on treatment with abiraterone in men with de novo metastatic castration sensitive prostate cancer: a drug utilization study

Mortality in men with castration‐resistant prostate cancer—A long‐term follow‐up of a population‐based real‐world cohort

Khoshkar, Yashar; Westerberg, Marcus; Adolfsson, Jan; Bill-Axelson, Anna et al.

Part of BJUI Compass, p. 173-183, 2022

• DOI for Mortality in men with castration‐resistant prostate cancer—A long‐term follow‐up of a population‐based real‐world cohort
• Download full text (pdf) of Mortality in men with castration‐resistant prostate cancer—A long‐term follow‐up of a population‐based real‐world cohort

Diagnostic activity impacts lifetime risk of prostate cancer diagnosis more strongly than life expectancy

Wilberg Orrason, Andri; Westerberg, Marcus; Albertsen, Peter; Styrke, Johan et al.

Part of PLOS ONE, 2022

• DOI for Diagnostic activity impacts lifetime risk of prostate cancer diagnosis more strongly than life expectancy
• Download full text (pdf) of Diagnostic activity impacts lifetime risk of prostate cancer diagnosis more strongly than life expectancy

Time without PSA recurrence after radical prostatectomy as a predictor of future biochemical recurrence, metastatic disease and prostate cancer death: a prospective Scandinavian cohort study

Ahlberg, Mats Steinholtz; Garmo, Hans; Adami, Hans-Olov; Andren, Ove et al.

Part of BMJ Open, 2022

• DOI for Time without PSA recurrence after radical prostatectomy as a predictor of future biochemical recurrence, metastatic disease and prostate cancer death: a prospective Scandinavian cohort study
• Download full text (pdf) of Time without PSA recurrence after radical prostatectomy as a predictor of future biochemical recurrence, metastatic disease and prostate cancer death: a prospective Scandinavian cohort study

Modeling Disease Trajectories for Castration-resistant Prostate Cancer Using Nationwide Population-based Data

Ventimiglia, Eugenio; Bill-Axelson, Anna; Adolfsson, Jan; Aly, Markus et al.

Part of European Urology Open Science, p. 46-51, 2022

• DOI for Modeling Disease Trajectories for Castration-resistant Prostate Cancer Using Nationwide Population-based Data
• Download full text (pdf) of Modeling Disease Trajectories for Castration-resistant Prostate Cancer Using Nationwide Population-based Data

Long-term Outcomes Among Men Undergoing Active Surveillance for Prostate Cancer in Sweden

Ventimiglia, Eugenio; Bill-Axelson, Anna; Bratt, Ola; Montorsi, Francesco et al.

Part of JAMA Network Open, 2022

• DOI for Long-term Outcomes Among Men Undergoing Active Surveillance for Prostate Cancer in Sweden
• Download full text (pdf) of Long-term Outcomes Among Men Undergoing Active Surveillance for Prostate Cancer in Sweden

Time to castration-resistant prostate cancer and prostate cancer death according to PSA response in men with non-metastatic prostate cancer treated with gonadotropin releasing hormone agonists

Bonde, Tiago M.; Westerberg, Marcus; Aly, Markus; Eklund, Martin et al.

Part of Scandinavian journal of urology, p. 169-175, 2022

• DOI for Time to castration-resistant prostate cancer and prostate cancer death according to PSA response in men with non-metastatic prostate cancer treated with gonadotropin releasing hormone agonists
• Download full text (pdf) of Time to castration-resistant prostate cancer and prostate cancer death according to PSA response in men with non-metastatic prostate cancer treated with gonadotropin releasing hormone agonists

Primary small intestinal neuroendocrine tumors are highly prevalent and often multiple before metastatic disease develops

Eriksson, John; Norlén, Olov; Ögren, M.; Garmo, Hans et al.

Part of Scandinavian Journal of Surgery, p. 44-50, 2021

• DOI for Primary small intestinal neuroendocrine tumors are highly prevalent and often multiple before metastatic disease develops

Temporal changes in cause-specific death in men with localised prostate cancer treated with radical prostatectomy: a population-based, nationwide study

Thomsen, Frederik B; Garmo, Hans; Brasso, Klaus; Egevad, Lars et al.

Part of Journal of Surgical Oncology, p. 867-875, 2021

• DOI for Temporal changes in cause-specific death in men with localised prostate cancer treated with radical prostatectomy: a population-based, nationwide study
• Download full text (pdf) of Temporal changes in cause-specific death in men with localised prostate cancer treated with radical prostatectomy: a population-based, nationwide study

Association between serum markers of the humoral immune system and inflammation in the Swedish AMORIS study

Santaolalla, Aida; Sollie, Sam; Rislan, Ali; Josephs, Debra H. et al.

Part of BMC Immunology, 2021

• DOI for Association between serum markers of the humoral immune system and inflammation in the Swedish AMORIS study
• Download full text (pdf) of Association between serum markers of the humoral immune system and inflammation in the Swedish AMORIS study

Data Resource Profile: Breast Cancer Data Base Sweden 2.0 (BCBaSe 2.0)

Wadsten, Charlotta; Wennstig, Anna-Karin; Garmo, Hans; Lambe, Mats et al.

Part of International Journal of Epidemiology, p. 1770-1771f, 2021

• DOI for Data Resource Profile: Breast Cancer Data Base Sweden 2.0 (BCBaSe 2.0)

Time on treatment with abiraterone and enzalutamide in the Patient-overview Prostate Cancer in The National Prostate Cancer Register of Sweden

Fallara, Giuseppe; Alverbratt, Charlotte; Garmo, Hans; Vikman, Hanna et al.

Part of Acta Oncologica, p. 1589-1596, 2021

• DOI for Time on treatment with abiraterone and enzalutamide in the Patient-overview Prostate Cancer in The National Prostate Cancer Register of Sweden
• Download full text (pdf) of Time on treatment with abiraterone and enzalutamide in the Patient-overview Prostate Cancer in The National Prostate Cancer Register of Sweden

Risk of primary lung cancer after adjuvant radiotherapy in breast cancer: a large population-based study

Wennstig, Anna-Karin; Wadsten, Charlotta; Garmo, Hans; Johansson, Mikael et al.

Part of npj Breast Cancer, 2021

• DOI for Risk of primary lung cancer after adjuvant radiotherapy in breast cancer: a large population-based study
• Download full text (pdf) of Risk of primary lung cancer after adjuvant radiotherapy in breast cancer: a large population-based study

A drug comorbidity index to predict mortality in men with castration resistant prostate cancer

Fallara, Giuseppe; Gedeborg, Rolf; Bill-Axelson, Anna; Garmo, Hans et al.

Part of PLOS ONE, 2021

• DOI for A drug comorbidity index to predict mortality in men with castration resistant prostate cancer
• Download full text (pdf) of A drug comorbidity index to predict mortality in men with castration resistant prostate cancer

Simulation model of disease incidence driven by diagnostic activity

Westerberg, Marcus; Larsson, Rolf; Holmberg, Lars; Stattin, Pär et al.

Part of Statistics in Medicine, p. 1172-1188, 2021

• DOI for Simulation model of disease incidence driven by diagnostic activity
• Download full text (pdf) of Simulation model of disease incidence driven by diagnostic activity

An Aggregated Comorbidity Measure Based on History of Filled Drug Prescriptions: Development and Evaluation in Two Separate Cohorts

Gedeborg, Rolf; Sund, Malin; Lambe, Mats; Plym, Anna et al.

Part of Epidemiology, p. 607-615, 2021

• DOI for An Aggregated Comorbidity Measure Based on History of Filled Drug Prescriptions: Development and Evaluation in Two Separate Cohorts

Risk of cardiovascular events in men on abiraterone or enzalutamide combined with GnRH agonists: nation-wide, population-based cohort study in Sweden

George, Gincy; Vikman, Hanna; Gedeborg, Rolf; Franck Lissbrant, Ingela et al.

Part of Acta Oncologica, p. 459-465, 2021

• DOI for Risk of cardiovascular events in men on abiraterone or enzalutamide combined with GnRH agonists: nation-wide, population-based cohort study in Sweden
• Download full text (pdf) of Risk of cardiovascular events in men on abiraterone or enzalutamide combined with GnRH agonists: nation-wide, population-based cohort study in Sweden

Short-term ciprofloxacin prophylaxis for prostate biopsy and risk of aortic aneurysm. Nationwide, population-based cohort study

Lundstrom, Karl-Johan; Garmo, Hans; Gedeborg, Rolf; Stattin, Pär et al.

Part of Scandinavian journal of urology, p. 221-226, 2021

• DOI for Short-term ciprofloxacin prophylaxis for prostate biopsy and risk of aortic aneurysm. Nationwide, population-based cohort study

No generally increased risk of cancer after total hip arthroplasty performed due to osteoarthritis

Hailer, Nils P.; Garland, Anne; Gordon, Max; Karrholm, Johan et al.

Part of International Journal of Cancer, p. 76-83, 2020

• DOI for No generally increased risk of cancer after total hip arthroplasty performed due to osteoarthritis
• Download full text (pdf) of No generally increased risk of cancer after total hip arthroplasty performed due to osteoarthritis

Observational study on time on treatment with abiraterone and enzalutamide

Fallara, Giuseppe; Lissbrant, Ingela Franck; Styrke, Johan; Montorsi, Francesco et al.

Part of PLOS ONE, 2020

• DOI for Observational study on time on treatment with abiraterone and enzalutamide
• Download full text (pdf) of Observational study on time on treatment with abiraterone and enzalutamide

Opioid Use after Radical Prostatectomy: Nationwide, Population Based Study in Sweden

Loeb, Stacy; Cazzaniga, Walter; Robinson, David; Garmo, Hans et al.

Part of Journal of Urology, p. 145-150, 2020

• DOI for Opioid Use after Radical Prostatectomy: Nationwide, Population Based Study in Sweden

Temporal changes in survival in men with de novo metastatic prostate cancer: nationwide population-based study

Westerberg, Marcus; Franck Lissbrant, Ingela; Damber, Jan Erik; Robinson, David et al.

Part of Acta Oncologica, p. 106-111, 2020

• DOI for Temporal changes in survival in men with de novo metastatic prostate cancer: nationwide population-based study
• Download full text (pdf) of Temporal changes in survival in men with de novo metastatic prostate cancer: nationwide population-based study

Changes in lifestyle among prostate cancer survivors: A nationwide population-based study

Bergengren, Oskar; Enblad, Anna Pia; Garmo, Hans; Bratt, Ola et al.

Part of Psycho-Oncology, p. 1713-1719, 2020

• DOI for Changes in lifestyle among prostate cancer survivors: A nationwide population-based study
• Download full text (pdf) of Changes in lifestyle among prostate cancer survivors: A nationwide population-based study

Changes in treatment and mortality in men with locally advanced prostate cancer between 2000 and 2016: a nationwide, population-based study in Sweden

Orrason, Andri Wilberg; Westerberg, Marcus; Garmo, Hans; Lissbrant, Ingela Franck et al.

Part of BJU International, p. 142-151, 2020

• DOI for Changes in treatment and mortality in men with locally advanced prostate cancer between 2000 and 2016: a nationwide, population-based study in Sweden
• Download full text (pdf) of Changes in treatment and mortality in men with locally advanced prostate cancer between 2000 and 2016: a nationwide, population-based study in Sweden

PSA testing patterns in a large Swedish cohort before the implementation of organized PSA testing

Enblad, Anna Pia; Bergengren, Oskar; Andrén, Ove; Larsson, Anders et al.

Part of Scandinavian journal of urology, p. 376-381, 2020

• DOI for PSA testing patterns in a large Swedish cohort before the implementation of organized PSA testing
• Download full text (pdf) of PSA testing patterns in a large Swedish cohort before the implementation of organized PSA testing

Prescription-based prediction of baseline mortality risk among older men

Gedeborg, Rolf; Garmo, Hans; Robinson, David; Stattin, Pär

Part of PLOS ONE, 2020

• DOI for Prescription-based prediction of baseline mortality risk among older men
• Download full text (pdf) of Prescription-based prediction of baseline mortality risk among older men

5 alpha-Reductase Inhibitors and Risk of Prostate Cancer Death

Miranda, Tiago Bonde; Garmo, Hans; Stattin, Pär; Robinson, David

Part of Journal of Urology, p. 714-719, 2020

• DOI for 5 alpha-Reductase Inhibitors and Risk of Prostate Cancer Death

Baseline serum folate, vitamin B12 and the risk of prostate and breast cancer using data from the Swedish AMORIS cohort

Essen, Anneli; Santaolalla, Aida; Garmo, Hans; Hammar, Niklas et al.

Part of Cancer Causes and Control, p. 603-615, 2019

• DOI for Baseline serum folate, vitamin B12 and the risk of prostate and breast cancer using data from the Swedish AMORIS cohort
• Download full text (pdf) of Baseline serum folate, vitamin B12 and the risk of prostate and breast cancer using data from the Swedish AMORIS cohort

Radical Surgery or Watchful Waiting in Prostate Cancer Reply

Bill-Axelson, Anna; Holmberg, Lars; Garmo, Hans

Part of New England Journal of Medicine, p. 1084-1084, 2019

• DOI for Radical Surgery or Watchful Waiting in Prostate Cancer Reply

Androgen deprivation therapy for prostate cancer and risk of dementia

Robinson, David; Garmo, Hans; Van Hemelrijck, Mieke; Damber, Jan-Erik et al.

Part of BJU International, p. 87-92, 2019

• DOI for Androgen deprivation therapy for prostate cancer and risk of dementia
• Download full text (pdf) of Androgen deprivation therapy for prostate cancer and risk of dementia

Mortality after radical prostatectomy in a matched contemporary cohort in Sweden compared to the Scandinavian Prostate Cancer Group 4 (SPCG-4) study

Cazzaniga, Walter; Garmo, Hans; Robinson, David; Holmberg, Lars et al.

Part of BJU International, p. 421-428, 2019

• DOI for Mortality after radical prostatectomy in a matched contemporary cohort in Sweden compared to the Scandinavian Prostate Cancer Group 4 (SPCG-4) study

How to measure temporal changes in care pathways for chronic diseases using health care registry data

Ventimiglia, Eugenio; Van Hemelrijck, Mieke; Lindhagen, Lars; Stattin, Pär et al.

Part of BMC Medical Informatics and Decision Making, 2019

• DOI for How to measure temporal changes in care pathways for chronic diseases using health care registry data
• Download full text (pdf) of How to measure temporal changes in care pathways for chronic diseases using health care registry data

PCASTt/SPCG-17-a randomised trial of active surveillance in prostate cancer: rationale and design

Ahlberg, Mats Steinholtz; Adami, Hans-Olov; Beckmann, Kerri; Bertilsson, Helena et al.

Part of BMJ Open, 2019

• DOI for PCASTt/SPCG-17-a randomised trial of active surveillance in prostate cancer: rationale and design
• Download full text (pdf) of PCASTt/SPCG-17-a randomised trial of active surveillance in prostate cancer: rationale and design

Anti-androgen monotherapy versus gonadotropin-releasing hormone agonists in men with advanced, non-metastatic prostate cancer: a register-based, observational study

Thomsen, Frederik Birkebaek; Bosco, Cecilia; Garmo, Hans; Adolfsson, Jan et al.

Part of Acta Oncologica, p. 110-118, 2019

• DOI for Anti-androgen monotherapy versus gonadotropin-releasing hormone agonists in men with advanced, non-metastatic prostate cancer: a register-based, observational study
• Download full text (pdf) of Anti-androgen monotherapy versus gonadotropin-releasing hormone agonists in men with advanced, non-metastatic prostate cancer: a register-based, observational study

Prognostic factors for death after surgery for small intestinal neuroendocrine tumours

Eriksson, John; Garmo, Hans; Ihre-Lundgren, C; Hellman, Per

Part of BJS Open, p. 345-352, 2018

• DOI for Prognostic factors for death after surgery for small intestinal neuroendocrine tumours
• Download full text (pdf) of Prognostic factors for death after surgery for small intestinal neuroendocrine tumours

Leukemic transformation and second cancers in 3649 patients with high-risk essential thrombocythemia in the EXELS study

Birgegård, Gunnar; Folkvaljon, Folke; Garmo, Hans; Holmberg, Lars et al.

Part of Leukemia Research, p. 105-109, 2018

• DOI for Leukemic transformation and second cancers in 3649 patients with high-risk essential thrombocythemia in the EXELS study

Heterogeneity in risk of prostate cancer: A Swedish population-based cohort study of competing risks and Type 2 diabetes mellitus

Häggström, Christel; Van Hemelrijck, Mieke; Garmo, Hans; Robinson, David et al.

Part of International Journal of Cancer, p. 1868-1875, 2018

• DOI for Heterogeneity in risk of prostate cancer: A Swedish population-based cohort study of competing risks and Type 2 diabetes mellitus
• Download full text (pdf) of Heterogeneity in risk of prostate cancer: A Swedish population-based cohort study of competing risks and Type 2 diabetes mellitus

Thyroid cancer risk in the Swedish AMORIS study: the role of inflammatory biomarkers in serum.

Ghoshal, Arunangshu; Garmo, Hans; Arthur, Rhonda; Carroll, Paul et al.

Part of Oncotarget, p. 774-782, 2018

• DOI for Thyroid cancer risk in the Swedish AMORIS study: the role of inflammatory biomarkers in serum.
• Download full text (pdf) of Thyroid cancer risk in the Swedish AMORIS study: the role of inflammatory biomarkers in serum.

Biomarkers in DCIS associated with breast cancer death

Wadsten, C.; Wärnberg, Fredrik; Tolockiene, E.; Hartman, J. et al.

Part of European Journal of Cancer, 2018

Reply to the letter to the editor 'Age at diagnosis and prognosis among prostate cancer patients treated with radiotherapy: evidenced from three independent cohort studies' by X. Dong, G. Ma and F. Chen

Pettersson, A.; Robinson, D.; Garmo, Hans; Holmberg, Lars et al.

Part of Annals of Oncology, p. 2020-2021, 2018

• DOI for Reply to the letter to the editor 'Age at diagnosis and prognosis among prostate cancer patients treated with radiotherapy: evidenced from three independent cohort studies' by X. Dong, G. Ma and F. Chen

Radical Prostatectomy or Watchful Waiting in Prostate Cancer: 29-Year Follow-up

Bill-Axelson, Anna; Holmberg, Lars; Garmo, Hans; Taari, Kimmo et al.

Part of New England Journal of Medicine, p. 2319-2329, 2018

• DOI for Radical Prostatectomy or Watchful Waiting in Prostate Cancer: 29-Year Follow-up

Can pre-diagnostic serum levels of sodium and potassium predict prostate cancer survival?

Ghoshal, Arunangshu; Garmo, Hans; Hammar, Niklas; Jungner, Ingmar et al.

Part of BMC Cancer, 2018

• DOI for Can pre-diagnostic serum levels of sodium and potassium predict prostate cancer survival?
• Download full text (pdf) of Can pre-diagnostic serum levels of sodium and potassium predict prostate cancer survival?

Serum inflammatory markers in relation to prostate cancer severity and death in the Swedish AMORIS study

Arthur, R.; Williams, R.; Garmo, Hans; Holmberg, Lars et al.

Part of International Journal of Cancer, p. 2254-2262, 2018

• DOI for Serum inflammatory markers in relation to prostate cancer severity and death in the Swedish AMORIS study

Abstract GS5-08: A validation of DCIS biological risk profile in a randomised study for radiation therapy with 20 year follow-up (SweDCIS)

Wärnberg, Fredrik; Garmo, Hans; Folkvaljon, Yasin; Holmberg, Lars et al.

Part of Cancer Research, 2018

• DOI for Abstract GS5-08: A validation of DCIS biological risk profile in a randomised study for radiation therapy with 20 year follow-up (SweDCIS)

The Influence of Preoperative Symptoms on the Death of Patients with Small Intestinal Neuroendocrine Tumors

Eriksson, John; Garmo, Hans; Hellman, Per; Ihre-Lundgren, Catharina

Part of Annals of Surgical Oncology, p. 1214-1220, 2017

• DOI for The Influence of Preoperative Symptoms on the Death of Patients with Small Intestinal Neuroendocrine Tumors
• Download full text (pdf) of The Influence of Preoperative Symptoms on the Death of Patients with Small Intestinal Neuroendocrine Tumors

Gonadotropin-releasing Hormone Agonists, Orchiectomy, and Risk of Cardiovascular Disease: Semi-ecologic, Nationwide, Population-based Study

Thomsen, Frederik Birkebæk; Sandin, Fredrik; Garmo, Hans; Lissbrant, Ingela Franck et al.

Part of European Urology, p. 920-928, 2017

• DOI for Gonadotropin-releasing Hormone Agonists, Orchiectomy, and Risk of Cardiovascular Disease: Semi-ecologic, Nationwide, Population-based Study
• Download full text (pdf) of Gonadotropin-releasing Hormone Agonists, Orchiectomy, and Risk of Cardiovascular Disease: Semi-ecologic, Nationwide, Population-based Study

DCIS and the risk of breast cancer death - A case control study

Wadsten, C.; Garmo, Hans; Fredriksson, I.; Sund, M. et al.

Part of Cancer Research, 2017

• DOI for DCIS and the risk of breast cancer death - A case control study

Use of palliative medications before death from prostate cancer: a population based study

Lycken, Magdalena; Drevin, Linda; Garmo, Hans; Stattin, Pär et al.

Part of Scandinavian journal of urology, p. 25-26, 2017

• DOI for Use of palliative medications before death from prostate cancer: a population based study

Serum biomarkers to predict risk of testicular and penile cancer in AMORIS

Ghoshal, Arunangshu; Garmo, Hans; Arthur, Rhonda; Hammar, Niklas et al.

Part of ecancermedicalscience, 2017

• DOI for Serum biomarkers to predict risk of testicular and penile cancer in AMORIS
• Download full text (pdf) of Serum biomarkers to predict risk of testicular and penile cancer in AMORIS

No difference in risk of cardiovascular disease in men with prostate cancer treated with GnRH agonists or orchiectomy: semi-ecologic, nationwide, population-based study

Thomsen, Frederik B.; Sandin, Fredrik; Garmo, Hans; Lissbrant, Ingela F. et al.

Part of Scandinavian journal of urology, p. 16-16, 2017

• DOI for No difference in risk of cardiovascular disease in men with prostate cancer treated with GnRH agonists or orchiectomy: semi-ecologic, nationwide, population-based study

The association between individual metabolic syndrome components, primary liver cancer and cirrhosis: A study in the Swedish AMORIS cohort

Nderitu, Paul; Bosco, Cecilia; Garmo, Hans; Holmberg, Lars et al.

Part of International Journal of Cancer, p. 1148-1160, 2017

• DOI for The association between individual metabolic syndrome components, primary liver cancer and cirrhosis: A study in the Swedish AMORIS cohort

LEUKEMIC TRANSFORMATION AND SECOND CANCERS IN 3649 HIGH RISK ET PATIENTS IN THE EXELS STUDY

Birgegård, Gunnar; Folkvaljon, Yasin; Garmo, Hans; Holmberg, Lars et al.

Part of Haematologica, p. 282-282, 2017

Causes of death in men with localized prostate cancer: a nationwide, population-based study.

Van Hemelrijck, Mieke; Folkvaljon, Yasin; Adolfsson, Jan; Akre, Olof et al.

Part of BJU International, p. 507-514, 2016

• DOI for Causes of death in men with localized prostate cancer: a nationwide, population-based study.
• Download full text (pdf) of Causes of death in men with localized prostate cancer: a nationwide, population-based study.

Family History and Probability of Prostate Cancer, Differentiated by Risk Category: A Nationwide Population-Based Study

Bratt, Ola; Drevin, Linda; Akre, Olof; Garmo, Hans et al.

Part of Journal of the National Cancer Institute, 2016

• DOI for Family History and Probability of Prostate Cancer, Differentiated by Risk Category: A Nationwide Population-Based Study
• Download full text (pdf) of Family History and Probability of Prostate Cancer, Differentiated by Risk Category: A Nationwide Population-Based Study

Association between duration and type of androgen deprivation therapy and risk of diabetes in men with prostate cancer

Crawley, Danielle; Garmo, Hans; Rudman, Sarah; Stattin, Pär et al.

Part of International Journal of Cancer, p. 2698-2704, 2016

• DOI for Association between duration and type of androgen deprivation therapy and risk of diabetes in men with prostate cancer
• Download full text (pdf) of Association between duration and type of androgen deprivation therapy and risk of diabetes in men with prostate cancer

Cohort Profile Update: The National Prostate Cancer Register of Sweden and Prostate Cancer data Base--a refined prostate cancer trajectory.

Van Hemelrijck, Mieke; Garmo, Hans; Wigertz, Annette; Nilsson, Per et al.

Part of International Journal of Epidemiology, p. 73-82, 2016

• DOI for Cohort Profile Update: The National Prostate Cancer Register of Sweden and Prostate Cancer data Base--a refined prostate cancer trajectory.

Interpretation of conventional survival analysis and competing-risk analysis: an example of hypertension and prostate cancer

Häggström, Christel; Stattin, Pär; Stocks, Tanja; Garmo, Hans et al.

Part of BJU International, p. 850-852, 2016

• DOI for Interpretation of conventional survival analysis and competing-risk analysis: an example of hypertension and prostate cancer
• Download full text (pdf) of Interpretation of conventional survival analysis and competing-risk analysis: an example of hypertension and prostate cancer

Serum Calcium and the Risk of Breast Cancer: Findings from the Swedish AMORIS Study and a Meta-Analysis of Prospective Studies

Wulaningsih, Wahyu; Sagoo, Harkiran K.; Hamza, Mustafa; Melvin, Jennifer et al.

Part of International Journal of Molecular Sciences, 2016

• DOI for Serum Calcium and the Risk of Breast Cancer: Findings from the Swedish AMORIS Study and a Meta-Analysis of Prospective Studies
• Download full text (pdf) of Serum Calcium and the Risk of Breast Cancer: Findings from the Swedish AMORIS Study and a Meta-Analysis of Prospective Studies

Risk and Timing of Cardiovascular Disease After Androgen-Deprivation Therapy in Men With Prostate Cancer

O'Farrell, Sean; Garmo, Hans; Holmberg, Lars; Adolfsson, Jan et al.

Part of Journal of Clinical Oncology, p. 1243-1251, 2015

• DOI for Risk and Timing of Cardiovascular Disease After Androgen-Deprivation Therapy in Men With Prostate Cancer

How to model temporal changes in comorbidity for cancer patients using prospective cohort data

Lindhagen, Lars; Van Hemelrijck, Mieke; Robinson, David; Stattin, Pär et al.

Part of BMC Medical Informatics and Decision Making, 2015

• DOI for How to model temporal changes in comorbidity for cancer patients using prospective cohort data
• Download full text (pdf) of How to model temporal changes in comorbidity for cancer patients using prospective cohort data

5-alpha reductase inhibitors, benign prostatic hyperplasia, and risk of male breast cancer

Robinson, David; Garmo, Hans; Holmberg, Lars; Stattin, Pär

Part of Cancer Causes and Control, p. 1289-1297, 2015

• DOI for 5-alpha reductase inhibitors, benign prostatic hyperplasia, and risk of male breast cancer
• Download full text (pdf) of 5-alpha reductase inhibitors, benign prostatic hyperplasia, and risk of male breast cancer

Prediagnostic serum inflammatory markers in relation to breast cancer risk, severity at diagnosis and survival in breast cancer patients

Wulaningsih, Wahyu; Holmberg, Lars; Garmo, Hans; Malmstrom, Håkan et al.

Part of Carcinogenesis, p. 1121-1128, 2015

• DOI for Prediagnostic serum inflammatory markers in relation to breast cancer risk, severity at diagnosis and survival in breast cancer patients

Risk of Fractures and Falls during and after 5-α Reductase Inhibitor Use: A Nationwide Cohort Study

Robinson, David; Garmo, Hans; Stattin, Pär; Michaëlsson, Karl

Part of PLOS ONE, 2015

• DOI for Risk of Fractures and Falls during and after 5-α Reductase Inhibitor Use: A Nationwide Cohort Study
• Download full text (pdf) of Risk of Fractures and Falls during and after 5-α Reductase Inhibitor Use: A Nationwide Cohort Study

An investigation into the relationship between Statins and Cancer using population-based data

Melvin, Jennifer C; Garmo, Hans; Daniel, Rhian; Shanmugalingam, Thurkaa et al.

Part of BJU International, p. 681-683, 2015

• DOI for An investigation into the relationship between Statins and Cancer using population-based data

Anabolic steroids and cardiovascular risk: A national population-based cohort study

Thiblin, Ingemar; Garmo, Hans; Garle, Mats; Holmberg, Lars et al.

Part of Drug And Alcohol Dependence, p. 87-92, 2015

• DOI for Anabolic steroids and cardiovascular risk: A national population-based cohort study

Prediagnostic serum glucose and lipids in relation to survival in breast cancer patients: a competing risk analysis

Wulaningsih, Wahyu; Vahdaninia, Mariam; Rowley, Mark; Holmberg, Lars et al.

Part of BMC Cancer, 2015

• DOI for Prediagnostic serum glucose and lipids in relation to survival in breast cancer patients: a competing risk analysis
• Download full text (pdf) of Prediagnostic serum glucose and lipids in relation to survival in breast cancer patients: a competing risk analysis

Radical Prostatectomy or Watchful Waiting in Early Prostate Cancer

Bill-Axelson, Anna; Holmberg, Lars; Garmo, Hans; Rider, Jennifer R. et al.

Part of New England Journal of Medicine, p. 932-942, 2014

• DOI for Radical Prostatectomy or Watchful Waiting in Early Prostate Cancer

Drug Prescription for Erectile Dysfunction Before and After Diagnosis of Localized Prostate Cancer

Plym, Anna; Folkvaljon, Yasin; Garmo, Hans; Holmberg, Lars et al.

Part of Journal of Sexual Medicine, p. 2100-2108, 2014

• DOI for Drug Prescription for Erectile Dysfunction Before and After Diagnosis of Localized Prostate Cancer

Genetic Markers of Toxicity From Capecitabine and Other Fluorouracil-Based Regimens: Investigation in the QUASAR2 Study, Systematic Review, and Meta-Analysis

Rosmarin, Dan; Palles, Claire; Church, David; Domingo, Enric et al.

Part of Journal of Clinical Oncology, p. 1031-1039, 2014

• DOI for Genetic Markers of Toxicity From Capecitabine and Other Fluorouracil-Based Regimens: Investigation in the QUASAR2 Study, Systematic Review, and Meta-Analysis

Nationwide Population Based Study of Infections after Transrectal Ultrasound Guided Prostate Biopsy

Lundstrom, Karl-Johan; Drevin, Linda; Carlsson, Stefan; Garmo, Hans et al.

Part of Journal of Urology, p. 1116-1122, 2014

• DOI for Nationwide Population Based Study of Infections after Transrectal Ultrasound Guided Prostate Biopsy

Dietary Patterns and Prostate Cancer Risk: Report from the Population Based ULSAM Cohort Study of Swedish Men

Ax, Erika; Garmo, Hans; Grundmark, Birgitta; Bill-Axelson, Anna et al.

Part of Nutrition and Cancer, p. 77-87, 2014

• DOI for Dietary Patterns and Prostate Cancer Risk: Report from the Population Based ULSAM Cohort Study of Swedish Men

Effect of Radiotherapy After Breast-Conserving Surgery for Ductal Carcinoma in Situ: 20 Years Follow-Up in the Randomized SweDCIS Trial

Wärnberg, Fredrik; Garmo, Hans; Emdin, Stefan; Hedberg, Veronica et al.

Part of Journal of Clinical Oncology, p. 3613-3618, 2014

• DOI for Effect of Radiotherapy After Breast-Conserving Surgery for Ductal Carcinoma in Situ: 20 Years Follow-Up in the Randomized SweDCIS Trial

Impact of hip fracture on mortality: a cohort study in hip fracture discordant identical twins

Michaëlsson, Karl; Nordström, Peter; Nordström, Anna; Garmo, Hans et al.

Part of Journal of Bone and Mineral Research, p. 424-431, 2014

• DOI for Impact of hip fracture on mortality: a cohort study in hip fracture discordant identical twins

Patterns of androgen deprivation therapies among men diagnosed with localised prostate cancer: A population-based study

Lycken, Magdalena; Garmo, Hans; Adolfsson, Jan; Stattin, Par et al.

Part of European Journal of Cancer, p. 1789-1798, 2014

• DOI for Patterns of androgen deprivation therapies among men diagnosed with localised prostate cancer: A population-based study

Breast cancer in young women - age a risk factor only in those not given chemotherapy

Fredholm, H.; Magnusson, Kristina; Lindstrom, L. S.; Garmo, Hans et al.

Part of The Breast, 2014

• DOI for Breast cancer in young women - age a risk factor only in those not given chemotherapy

Iron metabolism and risk of cancer in the Swedish AMORIS study

Gaur, Anjali; Collins, Helen; Wulaningsih, Wahyu; Holmberg, Lars et al.

Part of Cancer Causes and Control, p. 1393-1402, 2013

• DOI for Iron metabolism and risk of cancer in the Swedish AMORIS study
• Download full text (pdf) of Iron metabolism and risk of cancer in the Swedish AMORIS study

Fatherhood status and risk of prostate cancer: Nationwide, population-based case-control study

Wiren, Sara M.; Drevin, Linda I.; Carlsson, Sigrid V.; Akre, Olof et al.

Part of International Journal of Cancer, p. 937-943, 2013

• DOI for Fatherhood status and risk of prostate cancer: Nationwide, population-based case-control study

The interplay between lipid profiles, glucose, BMI and risk of kidney cancer in the Swedish AMORIS study

van Hemelrijck, Mieke; Garmo, Hans; Hammar, Niklas; Jungner, Ingmar et al.

Part of International Journal of Cancer, p. 2118-2128, 2013

• DOI for The interplay between lipid profiles, glucose, BMI and risk of kidney cancer in the Swedish AMORIS study

Population-based study on use of chemotherapy in men with castration resistant prostate cancer

Lissbrant, Ingela Franck; Garmo, Hans; Widmark, Anders; Stattin, Par

Part of Acta Oncologica, p. 1593-1601, 2013

• DOI for Population-based study on use of chemotherapy in men with castration resistant prostate cancer

Dietary Patterns and prostate cancer risk: a population based cohort study in elderly Swedish men

Ax, Erika Helena; Cederholm, Tommy; Grundmark, Birgitta; Bill-Axelson, Anna et al.

Part of The FASEB Journal, p. 847.8, 2013

Serum calcium and risk of gastrointestinal cancer in the Swedish AMORIS study

Wulaningsih, Wahyu; Michaelsson, Karl; Garmo, Hans; Hammar, Niklas et al.

Part of BMC Public Health, p. 663, 2013

• DOI for Serum calcium and risk of gastrointestinal cancer in the Swedish AMORIS study
• Download full text (pdf) of Serum calcium and risk of gastrointestinal cancer in the Swedish AMORIS study

Cohort Profile: The National Prostate Cancer Register of Sweden and Prostate Cancer data Base Sweden 2.0

Van Hemelrijck, Mieke; Wigertz, Annette; Sandin, Fredrik; Garmo, Hans et al.

Part of International Journal of Epidemiology, p. 956-967, 2013

• DOI for Cohort Profile: The National Prostate Cancer Register of Sweden and Prostate Cancer data Base Sweden 2.0

Inorganic phosphate and the risk of cancer in the Swedish AMORIS study

Wulaningsih, Wahyu; Michaelsson, Karl; Garmo, Hans; Hammar, Niklas et al.

Part of BMC Cancer, 2013

• DOI for Inorganic phosphate and the risk of cancer in the Swedish AMORIS study
• Download full text (pdf) of Inorganic phosphate and the risk of cancer in the Swedish AMORIS study

Mortality following Hip Fracture in Men with Prostate Cancer

van Hemelrijck, Mieke; Garmo, Hans; Michaëlsson, Karl; Thorstenson, Andreas et al.

Part of PLOS ONE, 2013

• DOI for Mortality following Hip Fracture in Men with Prostate Cancer
• Download full text (pdf) of Mortality following Hip Fracture in Men with Prostate Cancer

Long-term Distress After Radical Prostatectomy Versus Watchful Waiting in Prostate Cancer: A Longitudinal Study from the Scandinavian Prostate Cancer Group-4 Randomized Clinical Trial

Bill-Axelson, Anna; Garmo, Hans; Holmberg, Lars; Johansson, Jan-Erik et al.

Part of European Urology, p. 920-928, 2013

• DOI for Long-term Distress After Radical Prostatectomy Versus Watchful Waiting in Prostate Cancer: A Longitudinal Study from the Scandinavian Prostate Cancer Group-4 Randomized Clinical Trial

Use of 5 alpha-reductase inhibitors for lower urinary tract symptoms and risk of prostate cancer in Swedish men: nationwide, population based case-control study

Robinson, David; Garmo, Hans; Bill-Axelson, Anna; Mucci, Lorelei et al.

Part of The BMJ, 2013

• DOI for Use of 5 alpha-reductase inhibitors for lower urinary tract symptoms and risk of prostate cancer in Swedish men: nationwide, population based case-control study
• Download full text (pdf) of Use of 5 alpha-reductase inhibitors for lower urinary tract symptoms and risk of prostate cancer in Swedish men: nationwide, population based case-control study

Recent childbirth is an adverse prognostic factor in breast cancer and melanoma, but not in Hodgkin lymphoma

Moller, Henrik; Purushotham, Arnie; Linklater, Karen M.; Garmo, Hans et al.

Part of European Journal of Cancer, p. 3686-3693, 2013

• DOI for Recent childbirth is an adverse prognostic factor in breast cancer and melanoma, but not in Hodgkin lymphoma
• Download full text (pdf) of Recent childbirth is an adverse prognostic factor in breast cancer and melanoma, but not in Hodgkin lymphoma

Gamma-glutamyl transferase and c-reactive protein as alternative markers of metabolic abnormalities and their associated comorbidites: A prospective cohort study

Melvin, J. C.; Rodrigues, C.; Holmberg, Lars; Garmo, Hans et al.

Part of International Journal of Molecular Epidemiology and Genetics, p. 276-285, 2012

Biomarker-based score to predict mortality in persons aged 50 years and older: a new approach in the Swedish AMORIS study

van Hemelrijck, Mieke; Harari, Danielle; Garmo, Hans; Hammar, Niklas et al.

Part of International Journal of Molecular Epidemiology and Genetics, p. 66-76, 2012

Tumor stage affects risk and prognosis of contralateral breast cancer: results from a large Swedish-population-based study

Vichapat, Voralak; Garmo, Hans; Holmqvist, Marit; Liljegren, Göran et al.

Part of Journal of Clinical Oncology, p. 3478-3485, 2012

• DOI for Tumor stage affects risk and prognosis of contralateral breast cancer: results from a large Swedish-population-based study

Lipid profiles and the risk of endometrial cancer in the Swedish AMORIS study

Seth, Divya; Garmo, Hans; Wigertz, Annette; Holmberg, Lars et al.

Part of International Journal of Molecular Epidemiology and Genetics, p. 122-133, 2012

Multiple Events of Fractures and Cardiovascular and Thromboembolic Disease Following Prostate Cancer Diagnosis: Results From the Population-Based PCBaSe Sweden

van Hemelrijck, Mieke; Garmo, Hans; Holmberg, Lars; Stattin, Pär et al.

Part of European Urology, p. 690-700, 2012

• DOI for Multiple Events of Fractures and Cardiovascular and Thromboembolic Disease Following Prostate Cancer Diagnosis: Results From the Population-Based PCBaSe Sweden

Seasonal variations of insulin sensitivity from a euglycemic insulin clamp in elderly men

Berglund, Lars; Berne, Christian; Svärdsudd, Kurt; Garmo, Hans et al.

Part of Upsala Journal of Medical Sciences, p. 35-40, 2012

• DOI for Seasonal variations of insulin sensitivity from a euglycemic insulin clamp in elderly men

Serum Lipids and the Risk of Gastrointestinal Malignancies in the Swedish AMORIS Study

Wulaningsih, Wahyu; Garmo, Hans; Holmberg, Lars; Hammar, Niklas et al.

Part of Journal of Cancer Epidemiology, p. 792034, 2012

• DOI for Serum Lipids and the Risk of Gastrointestinal Malignancies in the Swedish AMORIS Study
• Download full text (pdf) of Serum Lipids and the Risk of Gastrointestinal Malignancies in the Swedish AMORIS Study

Distribution of Coronary Artery Stenosis After Radiation for Breast Cancer

Nilsson, Greger; Holmberg, Lars; Garmo, Hans; Duvernoy, Olov et al.

Part of Journal of Clinical Oncology, p. 380-386, 2012

• DOI for Distribution of Coronary Artery Stenosis After Radiation for Breast Cancer

Patterns of metastasis in women with metachronous contralateral breast cancer

Vichapat, V.; Garmo, Hans; Holmberg, Lars; Fentiman, I. S. et al.

Part of British Journal of Cancer, p. 221-223, 2012

• DOI for Patterns of metastasis in women with metachronous contralateral breast cancer

Anti-androgen prescribing patterns, patient treatment adherence and influencing factors: results from the nationwide PCBaSe Sweden

Grundmark, Birgitta; Garmo, Hans; Zethelius, Björn; Stattin, P et al.

Part of European Journal of Clinical Pharmacology, p. 1619-1630, 2012

• DOI for Anti-androgen prescribing patterns, patient treatment adherence and influencing factors: results from the nationwide PCBaSe Sweden

Serum calcium and incident and fatal prostate cancer in the Swedish AMORIS study

Van Hemelrijck, Mieke; Hermans, Ruben; Michaëlsson, Karl; Melvin, Jennifer et al.

Part of Cancer Causes and Control, p. 1349-1358, 2012

• DOI for Serum calcium and incident and fatal prostate cancer in the Swedish AMORIS study

Impaired glucose metabolism and diabetes and the risk of breast, endometrial, and ovarian cancer

Lambe, Mats; Wigertz, Annette; Garmo, Hans; Walldius, Göran et al.

Part of Cancer Causes and Control, p. 1163-1171, 2011

• DOI for Impaired glucose metabolism and diabetes and the risk of breast, endometrial, and ovarian cancer

Serum levels of selenium and smoking habits at age 50 influence long term prostate cancer risk; a 34 year ULSAM follow-up

Grundmark, Birgitta; Zethelius, Björn; Garmo, Hans; Holmberg, Lars

Part of BMC Cancer, p. 431, 2011

• DOI for Serum levels of selenium and smoking habits at age 50 influence long term prostate cancer risk; a 34 year ULSAM follow-up
• Download full text (pdf) of Serum levels of selenium and smoking habits at age 50 influence long term prostate cancer risk; a 34 year ULSAM follow-up

Mortality Among Men with Locally Advanced Prostate Cancer Managed with Noncurative Intent: A Nationwide Study in PCBaSe Sweden

Akre, Olof; Garmo, Hans; Adolfsson, Jan; Lambe, Mats et al.

Part of European Urology, p. 554-563, 2011

• DOI for Mortality Among Men with Locally Advanced Prostate Cancer Managed with Noncurative Intent: A Nationwide Study in PCBaSe Sweden

The Metabolic Syndrome and the Risk of Prostate Cancer under Competing Risks of Death from Other Causes

Grundmark, Birgitta; Garmo, Hans; Loda, Massimo; Busch, Christer et al.

Part of Cancer Epidemiology, Biomarkers and Prevention, p. 2088-2096, 2010

• DOI for The Metabolic Syndrome and the Risk of Prostate Cancer under Competing Risks of Death from Other Causes

Improved clinical outcome after acute myocardial infarction in hospitals participating in a Swedish quality improvement initiative

Carlhed, Rickard; Bojestig, Mats; Peterson, Anette; Åberg, Christina et al.

Part of Circulation. Cardiovascular quality and outcomes, p. 458-464, 2009

• DOI for Improved clinical outcome after acute myocardial infarction in hospitals participating in a Swedish quality improvement initiative

Maximum likelihood estimation of correction for dilution bias in simple linear regression using replicates from subjects with extreme first measurements

Berglund, Lars; Garmo, Hans; Lindbäck, Johan; Svärdsudd, Kurt et al.

Part of Statistics in Medicine, p. 4397-4407, 2008

• DOI for Maximum likelihood estimation of correction for dilution bias in simple linear regression using replicates from subjects with extreme first measurements

A randomized phase III multicenter trial comparing irinotecan in combination with the Nordic bolus 5-FU and folinic acid schedule or the bolus/infused de Gramont schedule (Lv5FU2) in patients with metastatic colorectal cancer

Glimelius, Bengt; Sørbye, H; Balteskard, L; Byström, P et al.

Part of Annals of Oncology, p. 909-914, 2008

• DOI for A randomized phase III multicenter trial comparing irinotecan in combination with the Nordic bolus 5-FU and folinic acid schedule or the bolus/infused de Gramont schedule (Lv5FU2) in patients with metastatic colorectal cancer

Increased incidence of stroke in women with breast cancer

Nilsson, Greger; Holmberg, Lars; Garmo, Hans; Terent, Andreas et al.

Part of European Journal of Cancer, p. 423-429, 2005

• DOI for Increased incidence of stroke in women with breast cancer

TFF3 in primary tumours has a negative impact on survival in small intestinal neuroendocrine tumours

Eriksson, John; Juhlin, Christofer; Backman, Samuel; Edfeldt, Katarina et al.

Primary small intestinal tumours are highly prevalent and often multiple before metastatic disease develops

Eriksson, John; Norlén, Olov; Ögren, Mats; Garmo, Hans et al.

Prognostic factors for death after surgery for small intestinal neuroendocrine tumours

Eriksson, John; Garmo, Hans; Ihre-Lundgren, Catharina; Hellman, Per

The Value of Real-World Data in Understanding Prostate Cancer Risk and Improving Clinical Care: Examples from Swedish Registries

Beckmann, Kerri; Garmo, Hans; Franck Lissbrant, Ingela; Stattin, Pär

Part of Cancers, 2021

• DOI for The Value of Real-World Data in Understanding Prostate Cancer Risk and Improving Clinical Care: Examples from Swedish Registries
• Download full text (pdf) of The Value of Real-World Data in Understanding Prostate Cancer Risk and Improving Clinical Care: Examples from Swedish Registries

Symptomatic disease at the time of surgery have prognostic impact in small intestinal neuroendocrine tumours

Eriksson, John; Garmo, Hans; Ihre-Lundgren, Catharina; Hellman, Per

Different assumptions about missingness in registration of metastatic status have important implications for following trends in cancer presentation

Westerberg, Marcus; Beckman, Kerri; Gedeborg, Rolf; Irenaeus, Sandra et al.

Random railways modelled as random 3-regular graphs

Garmo, Hans

1995